Related Experiment Video
Updated: Aug 20, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Targeted Therapy and Immunotherapy in Nonmelanoma Skin Cancer
Nader Aboul-Fettouh1, Shelby L Kubicki1, Leon Chen2
1Department of Dermatology, McGovern Medical School at the University of Texas Health Science Center at Houston, 6655 Travis St., #980 Houston, TX 77030, USA.
Advanced nonmelanoma skin cancers (NMSC) now have effective treatments. Modern therapies like hedgehog pathway inhibitors and programmed death-1 inhibitors offer better outcomes for advanced basal cell and squamous cell carcinomas.
Area of Science:
- Oncology
- Dermatology
Background:
- Advanced nonmelanoma skin cancers (NMSC) present challenges when tumors are not operable.
- Traditional chemotherapy for advanced NMSC showed limited efficacy and significant toxicity.
Purpose of the Study:
- To review modern therapeutic approaches for advanced NMSC.
- To highlight the efficacy of targeted therapies and immunotherapies.
Main Methods:
- Literature review of recent advancements in NMSC treatment.
- Analysis of clinical data for targeted and immune-based therapies.
Main Results:
- Hedgehog pathway inhibitors are effective first-line treatments for advanced basal cell carcinoma.
- Programmed death-1 inhibitors show promise as first-line therapy for advanced squamous cell carcinoma.
Conclusions:
- Modern targeted therapies and immunotherapies represent a significant advancement in treating advanced NMSC.
- These newer treatments offer improved response rates and tolerability compared to older methods.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

